| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Common Shares | 150,052 | $355,623 | $2.37 | 09 Dec 2025 | Direct |
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 120,600 | 27 Jan 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Restricted Stock Unit | 80,400 | 27 Jan 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Series A Common Warrants (right to buy) | 66,666 | 11 Jul 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Series B Common Warrants (right to buy) | 66,666 | 11 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | 09 Dec 2025 | 1 | $0 | 4 | Chief Commercial Officer | 11 Dec 2025, 16:15 |
| MIST | Milestone Pharmaceuticals Inc. | 11 Jul 2025 | 3 | $0 | 4 | Chief Commercial Officer | 15 Jul 2025, 16:15 |
| MIST | Milestone Pharmaceuticals Inc. | 27 Jan 2025 | 2 | $0 | 4 | Chief Commercial Officer | 29 Jan 2025, 16:15 |
| MIST | Milestone Pharmaceuticals Inc. | 16 Feb 2023 | 1 | $0 | 4 | Chief Commercial Officer | 17 Feb 2023, 15:52 |
| MIST | Milestone Pharmaceuticals Inc. | 21 Mar 2022 | 1 | $0 | 4 | Chief Commercial Officer | 23 Mar 2022, 21:46 |